Uterine hemangioma in pregnancy: A case report and review of the literature.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 01 03 2022
revised: 24 04 2022
accepted: 26 04 2022
pubmed: 2 5 2022
medline: 25 5 2022
entrez: 1 5 2022
Statut: ppublish

Résumé

Uterine hemangioma is a rare benign vascular tumor which can cause bleeding problems in various age groups. Current knowledge on this rare condition in pregnancy is limited. We report on a recent case of uterine hemangioma in a pregnancy that was already diagnosed during her first trimester. We also provide a literature review to summarize the characteristics and outcomes of uterine hemangioma cases in pregnant women. A systematic search was done of all published literature up to February 2021 using PubMed and Scopus databases. The selection process was registered using the online tool Rayyan QCRI. All data was described in a narrative format. The protocol was prospectively registered on PROSPERO (CRD42021237519). Fifteen case reports were included. In most cases, the diagnosis was established by antenatal ultrasound. More than half of the women developed a postpartum hemorrhage, necessitating a hysterectomy for bleeding control in half of the cases, although the risk for both seemed lower in those women in whom the hemangioma was diagnosed before delivery. One case of maternal mortality and two cases of fetal death were reported. There was one case of neonatal respiratory morbidity, although the neonatal data were not routinely reported upon. Current knowledge on uterine hemangioma in pregnancy is limited, but it seems to hold substantial risks for both pregnant women and their unborn child. We recommend routine screening for this condition at the standard mid-trimester anomaly scan. Pregnant women with uterine hemangioma should ideally be cared for in centers of expertise. An international registry will help to build a better understanding of this rare pathology.

Identifiants

pubmed: 35490987
pii: S2468-7847(22)00084-8
doi: 10.1016/j.jogoh.2022.102401
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102401

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No potential competing interest was reported by the authors.

Auteurs

Emma Bauters (E)

Department of Obstetrics and Gynaecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven 3000, Belgium.

Michael Aertsen (M)

Department of Radiology, University Hospitals Leuven, Herestraat 49, Leuven 3000, Belgium.

Wouter Froyman (W)

Department of Obstetrics and Gynaecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven 3000, Belgium.

Johannes van der Merwe (J)

Department of Obstetrics and Gynaecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven 3000, Belgium; Department of Development and Regeneration, Cluster Woman and Child, Faculty of Medicine, KU Leuven University, Herestraat 49, Leuven 3000, Belgium. Electronic address: hannes.vandermerwe@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH